Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

TransMedics Group Inc

TMDX
77,50
0,30 (0,39%)
Pre Mercato
Ultimo aggiornamento: 12:32:05
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/11/202422:05PRNUSTransMedics to Participate in the Piper Sandler 36th Annual..
07/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:10EDGAR2Form 144 - Report of proposed sale of securities
29/10/202421:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202421:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
29/10/202410:39IHMARKETNEWSHSBC Reports $8.5 Billion Profit; Boot Barn Announces New..
28/10/202421:11EDGAR2Form 8-K - Current report
28/10/202421:05PRNUSTransMedics Reports Third Quarter 2024 Financial Results
28/10/202411:12IHMARKETNEWSUS Futures Rise; Oil Prices Drop Over 5% as Middle East..
15/10/202422:05PRNUSTransMedics to Report Third Quarter 2024 Financial Results..
27/9/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
27/9/202400:04PRNUSThe Ensign Group Set to Join S&P MidCap 400; Curbline..
11/9/202422:05EDGAR2Form 8-K - Current report
29/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202423:32EDGAR2Form 144 - Report of proposed sale of securities
21/8/202422:05PRNUSTransMedics to Participate in the Morgan Stanley 22nd Annual..
20/8/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
09/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:25EDGAR2Form 144 - Report of proposed sale of securities
06/8/202422:12EDGAR2Form 144 - Report of proposed sale of securities
01/8/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202423:09EDGAR2Form 8-K - Current report
31/7/202422:05PRNUSTransMedics Reports Second Quarter 2024 Financial Results
29/7/202422:06EDGAR2Form 8-K - Current report
29/7/202422:05PRNUSTransMedics to Present at the Canaccord Genuity 44th Annual..
18/7/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
17/7/202422:05PRNUSTransMedics to Report Second Quarter 2024 Financial Results..
21/6/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
07/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:25EDGAR2Form 144 - Report of proposed sale of securities
05/6/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:06EDGAR2Form 144 - Report of proposed sale of securities
31/5/202422:38EDGAR2Form SD - Specialized disclosure report
31/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202423:19EDGAR2Form 144 - Report of proposed sale of securities
29/5/202423:08EDGAR2Form 144 - Report of proposed sale of securities
28/5/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:15EDGAR2Form 8-K - Current report
17/5/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
15/5/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202416:55EDGAR2Form 144 - Report of proposed sale of securities
08/5/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:08EDGAR2Form 144 - Report of proposed sale of securities
07/5/202400:08EDGAR2Form 144 - Report of proposed sale of securities
06/5/202416:54EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 77,20

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network